We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$82.5M
AUM Growth
+$17.6M
Cap. Flow
+$17.7M
Cap. Flow %
21.44%
Top 10 Hldgs %
81.1%
Holding
28
New
2
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$9.35M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$6.5M
3
HOOK
HOOKIPA Pharma
HOOK
+$5.79M
4
BTAI icon
BioXcel Therapeutics
BTAI
+$624K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.11%
2 Materials 4.76%
3 Industrials 2.96%
4 Financials 1.4%
5 Consumer Staples 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTAI icon
26
BioXcel Therapeutics
BTAI
$27.8M
$200K 0.24%
+1,875
New +$624K
AVDL
27
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-500,000
Closed -$4.58M
1
2

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Knoll Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Knoll Capital Management held 28 positions worth $82.5M, up 27% from $64.9M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Knoll Capital Management deployed $17.7M of net new capital in Q2 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Avadel Pharmaceuticals: 500,000 shares worth $8.24M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 66% a quarter earlier, followed by Materials and Industrials.

  • Knoll Capital Management's largest Q2 2023 buy was Avadel Pharmaceuticals: 500,000 shares worth $8.24M.
  • Knoll Capital Management added most to Aldeyra Therapeutics in Q2 2023, an estimated $9.35M increase.
  • Knoll Capital Management's ten largest holdings make up 81% of its $82.5M portfolio in Q2 2023.
  • Knoll Capital Management opened 2 new positions and closed 1 in Q2 2023.
  • Knoll Capital Management's portfolio value rose 27% quarter-over-quarter to $82.5M.

Based on Knoll Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.